All AbbVie grant requests originating from the United States and Puerto Rico are managed by a centralized grant department and more information is available at grants.abbvie.com. Support from the AbbVie Foundation, a nonprofit, 501(c)(3), is reported in an annual Internal Revenue Service 990-PF filing. This information is available at www.foundationcenter.org.
Additional grants and contributions disclosures for support paid separately by Pharmacyclics, an AbbVie company is available at pharmacyclics.com.
The list of AbbVie’s grants and contributions are provided in the annual reports below.
AbbVie’s reports reflect educational grants, patient support, corporate sponsorships, charitable donations, as well as fellowships and scholarships. The reports include individual direct payments of more than $200 from AbbVie’s US and Puerto Rico businesses. The reports may be updated periodically to reflect new data.
Annual Reports
AbbVie officially became a company January 1, 2013. In May 2020, AbbVie completed the acquisition of Allergan and began operating as a combined company.
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?